SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-019662
Filing Date
2024-07-17
Accepted
2024-07-17 16:15:04
Documents
2
Period of Report
2024-07-15

Document Format Files

Seq Description Document Type Size
1 form3-07172024_080759.html 3  
1 form3-07172024_080759.xml 3 1765
2 ex24-07172024_080759.htm EX-24 5881
  Complete submission text file 0001415889-24-019662.txt   9085
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Issuer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 22722 29TH DR SE SUITE 100 BOTHELL WA 98021
Business Address
Duty Stuart (Reporting) CIK: 0001970274 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38899 | Film No.: 241122396